𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level

✍ Scribed by Laurence Legros; Bohrane Slama; Jean-Michel Karsenti; Norbert Vey; Shanti Natarajan-Amé; Eric Watel; Bruno Richard; Krimo Bouabdallah; Lionel Mannone; Maxime Benchetrit; Irit Touitou; Sébastien Huault; Jérome Durivault; Damien Ambroseti; Anne-Odile Hueber; Pierre Fenaux; Francois Dreyfus; on behalf the Groupe Francophone des Myélodysplasies (GFM)


Publisher
Springer
Year
2011
Tongue
English
Weight
147 KB
Volume
91
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES